In other organ systems, selective loss of Capns1 in the pulmonary artery smooth muscle cells displays a protective effect in pulmonary hypertension and lung damage (22), suggesting that inhibiting this pathway may provide an avenue for novel therapeutics. Here, CAPNS1 is linked to pulmonary hypertension.